Finance

Lists
Why is AUPH down 3.06%?
Dive Deeper
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
$16.14
-3.06%
(-0.51) 1D
$16.08
-0.37% (-0.060)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
$16.67
High
$16.72
Low
$15.95
Mkt. cap
2.15B
Avg. vol.
784.94K
Volume
0.00
P/E ratio
7.05
52-wk high
$19.25
52-wk low
$12.79
EPS
$2.29
Beta
1.60
Shares outstanding
133.05M
No. of employees
128
Open
$16.67
High
$16.72
Low
$15.95
Mkt. cap
2.15B
Avg. vol.
784.94K
Volume
0.00
P/E ratio
7.05
52-wk high
$19.25
52-wk low
$12.79
EPS
$2.29
Beta
1.60
Shares outstanding
133.05M
No. of employees
128
News stories
From web sources and news partners
About Aurinia Pharmaceuticals Inc
CEO-
Employees128
Founded2012
HeadquartersEdmonton, Alberta, Canada
SectorBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current $16.14
$21.00 (+30.11%)
Average
$19.00 (+17.72%)
Lowest
$18.00 (+11.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Miehm
RBC Capital
Hold
Reiterated
$18.00
+11.5%
10/30/2026
Ken Cacciatore
TD Cowen
Buy
Reiterated
$18.00
+11.5%
10/21/2026
Stacy Ku
TD Cowen
Buy
Reiterated
$18.00
+11.5%
10/21/2026
David Martin PhD
Bloom Burton
Buy
Upgraded
$21.00
+30.1%
08/20/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$17.00
+5.3%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
77.11M
77.70M
83.22M
83.70M
Cost of goods sold
19.69M
13.98M
19.60M
24.92M
Cost of revenue
19.69M
13.98M
19.60M
24.92M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.26M
22.03M
23.51M
24.68M
Operating expense
14.48M
22.31M
17.27M
23.42M
Total operating expenses
34.18M
36.28M
36.88M
48.34M
Operating income
42.94M
41.42M
46.34M
35.36M
Other non operating income
-
-
-
-
EBT including unusual items
35.69M
43.92M
48.79M
38.72M
EBT excluding unusual items
35.69M
43.92M
48.79M
38.72M
Income tax expense
-175.10M
9.57M
11.37M
7.01M
Effective tax rate
-490.62%
21.79%
23.31%
18.11%
Other operating expenses
-14.77M
279.00K
-6.23M
-1.27M
Net income
210.79M
34.36M
37.41M
31.70M
Net profit margin
273.35%
44.21%
44.96%
37.88%
Earnings per share
1.53
0.25
0.28
0.23
Interest and investment income
3.50M
3.52M
3.39M
4.22M
Interest expense
-1.05M
-1.01M
-948.00K
-867.00K
Net interest expenses
2.45M
2.50M
2.44M
3.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
47.80M
46.24M
51.18M
40.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps